Table 2.
Prediction of depressive symptoms at the 2.5 year follow-up (T1) by SES1
| Complete sample (T0) | persons without elevated depressive symptoms at T0 | persons with elevated depressive symptoms at T0 | ||||
|---|---|---|---|---|---|---|
| PHQ-2 ≥ 2 at T1 (2898/12484) | PHQ-2 ≥ 2 at T1 (1455/9605) | PHQ-2 ≥ 2 at T1 (1443/2879) | ||||
| Adj. OR (95% CI) | p | Adj. OR (95% CI) | p | Adj. OR (95% CI) | p | |
| SES 1 | ||||||
| Model 1 | ||||||
| SES1 (range 3–21) | 0.96 (0.95–0.97) | < 0.0001 | 0.96 (0.95–0.98) | < 0.0001 | 0.99 (0.97–1.01) | 0.176 |
| SES1 (low-med-high) | 0.77 (0.72–0.83) | < 0.0001 | 0.76 (0.69–0.84) | < 0.0001 | 0.95 (0.84–1.07) | 0.391 |
| Model 2 | ||||||
| SES1 (range 3–21) | 0.97 (0.96–0.98) | < 0.0001 | 0.96 (0.95–0.98) | < 0.0001 | 0.98 (0.97–1.00) | 0.110 |
| SES1 (low-med-high) | 0.81 (0.75–0.88) | < 0.0001 | 0.76 (0.69–0.84) | < 0.0001 | 0.93 (0.82–1.06) | 0.265 |
Model 1 adjusted for sex, age, living with partner and major medical diseases
Model 2 adjusted for sex, age, living with partner, major medical diseases, PHQ-2 (T0), MH2 of depressive disorder, GAD-2 (T0) and MH2 of anxiety disorder
1SES Socioeconomic status
2MH Medical history
3Major medical diseases = any of the following diseases: CVD Cancer, diabetes, COPD Asthma
*boldface indicates p < 0.5 for odds ratios